Short answer · Medically reviewed summary · Last updated: 2026-05-08
Vestibular schwannoma, also known as acoustic neuroma, has an estimated annual incidence of approximately 1 to 2 cases per 100,000 people in the general population. While often classified as a rare condition, the true prevalence is likely higher due to many small, asymptomatic tumors remaining undiagnosed throughout a person’s lifetime. What is the prevalence and incidence of vestibular schwannoma? According to data from the NIH Genetic and Rare Diseases Information Center (GARD), vestibular schwannoma is considered a rare disease.
What is the prevalence of Vestibular Schwannoma-Acoustic neuroma?
Prevalence of Vestibular Schwannoma-Acoustic neuroma: how many people are affected worldwide, differences by sex and region, with sources.
Vestibular schwannoma, also known as acoustic neuroma, has an estimated annual incidence of approximately 1 to 2 cases per 100,000 people in the general population. While often classified as a rare condition, the true prevalence is likely higher due to many small, asymptomatic tumors remaining undiagnosed throughout a person’s lifetime.
What is the prevalence and incidence of vestibular schwannoma?
According to data from the NIH Genetic and Rare Diseases Information Center (GARD), vestibular schwannoma is considered a rare disease. While the annual incidence is roughly 1–2 per 100,000, autopsy studies suggest that microscopic vestibular schwannoma tumors may be present in up to 2% of the population, indicating a significant disparity between clinical diagnosis and actual biological occurrence.
Who is most commonly affected by vestibular schwannoma?
Vestibular schwannoma typically presents in adults between the ages of 30 and 60. There is no significant gender predilection, as men and women are affected with equal frequency. While vestibular schwannoma is rarely diagnosed in children, its presence in a pediatric patient should prompt clinical evaluation for Neurofibromatosis Type 2 (NF2), a genetic condition that significantly increases the risk of developing these tumors.
What factors complicate accurate prevalence data?
Several factors make tracking the exact number of people living with vestibular schwannoma challenging:
- Asymptomatic presentation: Many tumors grow very slowly or remain stable, never causing symptoms that lead to detection.
- Diagnostic variability: Access to high-resolution MRI imaging varies globally, impacting the rate of discovery.
- Misdiagnosis: Early symptoms like hearing loss or tinnitus are often attributed to age-related decline rather than vestibular schwannoma.
What does the community experience show?
The DiseaseMaps.org community currently includes 41 people with vestibular schwannoma-acoustic neuroma who have shared their experiences. This real-world data provides a vital perspective on the diagnostic journey, often highlighting that patients may consult multiple specialists before receiving a definitive diagnosis.
Next steps
- Consult an otolaryngologist (ENT) or neurotologist if you experience unilateral hearing loss or persistent tinnitus.
- Request an MRI with gadolinium contrast, which is the gold standard for diagnosing vestibular schwannoma.
- Join the DiseaseMaps.org community to connect with others who have navigated the diagnosis and treatment of this condition.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider.
References
- NIH Genetic and Rare Diseases (GARD) Information Center - Vestibular Schwannoma
- Orphanet: Vestibular Schwannoma
- OMIM (Online Mendelian Inheritance in Man) - Entry #101000
- Acoustic Neuroma Association (ANA) Clinical Resources
